The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology
Reference71 articles.
1. Translation of clinical research into practice: an impact assessment of the results from the Blood and Marrow Transplant Clinical Trials Network Protocol 0201 on Unrelated Graft Source Utilization;Khera;Biol Blood Marrow Transplant,2018
2. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy;Kollman;Blood,2016
3. Choosing wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's list of 5 tests and treatments to question in blood and marrow transplantation;Bhella;Biol Blood Marrow Transplant,2018
4. Blood and Marrow Transplant Clinical Trials Network. Peripheral-blood stem cells versus bone marrow from unrelated donors;Anasetti;N Engl J Med,2012
5. Canadian Bone Marrow Transplant Group. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplantations for myeloid malignancies;Couban;Blood,2002
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Addition of plerixafor in poorly mobilized allogeneic stem cell donors;Journal of Clinical Apheresis;2022-05-28
2. Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia;Clinical Management of Acute Lymphoblastic Leukemia;2022
3. Filgrastim (r‐met‐hu G‐CSF) enhances the efficiency of spermatogenesis in prepubertal Bos indicus bulls;Reproduction in Domestic Animals;2021-12-18
4. CXCR4 blockade reduces the severity of murine heart allograft rejection by plasmacytoid dendritic cell-mediated immune regulation;Scientific Reports;2021-12
5. Use of plerixafor to mobilize haematopoietic progenitor cells in healthy donors;Vox Sanguinis;2021-06-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3